Sporadic Kaposi Sarcoma Following a COVID-19 Vaccine : Mere Coincidence or Something More?
Copyright © 2024, Martínez-Ortega et al..
In this case report, we present a distinctive occurrence of classic Kaposi sarcoma (KS) in an individual of Latin origin, emerging seven days following the administration of the third dose of the ChAdOx1 nCoV-19 (AstraZeneca) vaccine. The progression of KS continued over two months, culminating in the development of a tumor. Given the absence of prior reports on KS development post-COVID-19 vaccination, the primary aim of this report is to explore the potential relationship between the ChAdOx1 nCoV-19 vaccine, reactivation of Kaposi sarcoma-associated herpes virus, and the subsequent onset of KS.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Cureus - 16(2024), 2 vom: 18. Feb., Seite e53925 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Martínez-Ortega, Jesús Iván [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Astrazeneca |
|---|
| Anmerkungen: |
Date Revised 12.03.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.7759/cureus.53925 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369548310 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369548310 | ||
| 003 | DE-627 | ||
| 005 | 20240312234437.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240311s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.7759/cureus.53925 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1324.xml |
| 035 | |a (DE-627)NLM369548310 | ||
| 035 | |a (NLM)38465101 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Martínez-Ortega, Jesús Iván |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sporadic Kaposi Sarcoma Following a COVID-19 Vaccine |b Mere Coincidence or Something More? |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 12.03.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2024, Martínez-Ortega et al. | ||
| 520 | |a In this case report, we present a distinctive occurrence of classic Kaposi sarcoma (KS) in an individual of Latin origin, emerging seven days following the administration of the third dose of the ChAdOx1 nCoV-19 (AstraZeneca) vaccine. The progression of KS continued over two months, culminating in the development of a tumor. Given the absence of prior reports on KS development post-COVID-19 vaccination, the primary aim of this report is to explore the potential relationship between the ChAdOx1 nCoV-19 vaccine, reactivation of Kaposi sarcoma-associated herpes virus, and the subsequent onset of KS | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a astrazeneca | |
| 650 | 4 | |a carcinogen | |
| 650 | 4 | |a covid-19 | |
| 650 | 4 | |a kaposi sarcoma | |
| 650 | 4 | |a kaposi tumor | |
| 650 | 4 | |a sars-cov-2 | |
| 650 | 4 | |a vaccine | |
| 700 | 1 | |a Ramirez Cibrian, Arely Gissell |e verfasserin |4 aut | |
| 700 | 1 | |a Martinez-Jaramillo, Elvis |e verfasserin |4 aut | |
| 700 | 1 | |a García Silva, Maria Del Consuelo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cureus |d 2013 |g 16(2024), 2 vom: 18. Feb., Seite e53925 |w (DE-627)NLM24118083X |x 2168-8184 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2024 |g number:2 |g day:18 |g month:02 |g pages:e53925 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.7759/cureus.53925 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2024 |e 2 |b 18 |c 02 |h e53925 | ||